Meta-analysis of binary outcomes from two-by-two tables when the length of follow-up varies and hazards are proportional

Statistical Methods in Medical Research

Volumn 20, Issue 5, 2011, Pages 531-540

  Combescure, C ^a   Courvoisier, D S ^a   Haller, G ^a   Perneger, T V ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FOLLOW UP; HUMAN; META ANALYSIS (TOPIC); PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SIMULATION; SURVIVAL RATE;

COLORECTAL NEOPLASMS; HUMANS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 80155210145     PISSN: 09622802     EISSN: 14770334     Source Type: Journal    
DOI: 10.1177/0962280210379172     Document Type: Article

References (21)

1. Pocock S. Meta-analysis. Statistical Methods in Medical Research 1993 ; 2 (2). 117-9.
2. Thornton A., Lee P. Publication bias in meta-analysis: its causes and consequences. Journal of Clinical Epidemiology 2000 ; 53 (2). 207-16. (Pubitemid 30151226)
3. Glasziou PP, Sanders SL Investigating causes of heterogeneity in systematic reviews. Statistics in Medicine 2002 ; 21 (11). 1503-11. (Pubitemid 34746059)
4. Duffy SW, Rohan TE, Altman DG The authors reply. American Journal of Epidemiology 1990 ; 132 (1). 198-9.
5. Greenland S. Re: "Those who were wrong ". American Journal of Epidemiology 1990 ; 132 (3). 585-6.
6. Perneger TV Estimating the relative hazard by the ratio of logarithms of event-free proportions. Contemporary Clinical Trials 2008 ; 29 (5). 762-6.
7. Symons MJ, Moore DT Hazard rate ratio and prospective epidemiological studies. Journal of Clinical Epidemiology 2002 ; 55 (9). 893-9. (Pubitemid 35246560)
8. Thompson SG Controversies in meta-analysis: the case of the trials of serum cholesterol reduction. Statistical Methods in Medical Research 1993 ; 2 (2). 173-92.
9. D'Amico R., Deeks JJ, Altman DG Numbers needed to treat derived from meta-analysis. Length of follow up is poorly reported. British Medical Journal 1999 ; 319 (7218). 1200.
10. Sutton AJ, Higgins JP Recent developments in meta-analysis. Statistics in Medicine 2008 ; 27 (5). 625-50. (Pubitemid 351278810)
11. Moodie PF, Nelson NA, Koch GG A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data. Stat Med 2004 ; 23 (7). 1075-93. (Pubitemid 38477068)
12. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002 ; 21 (11). 1539-58. (Pubitemid 34746062)
13. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986 ; 7 (3). 177-88.
14. Fleiss JL The statistical basis of meta-analysis. Statsitics Methods in Medical Research 1993 ; 2 (2). 121-45.
15. Sweeting MJ, Sutton AJ, Lambert PC What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Statistics in Medicine 2004 ; 23 (9). 1351-75. (Pubitemid 38594143)
16. Palliative chemotherapy for advanced or metastatic colorectal cancer. Colorectal Meta-analysis Collaboration. Cochrane Database of Systematic Reviews 2000 ; (2). CD001545.
17. Simmonds PC Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. British Medical Journal 2000 ; 321 (7260). 531-5.
18. Cunningham D., Pyrhonen S., James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998 ; 352 (9138). 1413-8. (Pubitemid 28510874)
19. Higgins JP, Thompson SG Controlling the risk of spurious findings from meta-regression. Statistics in Medicine 2004 ; 23 (11). 1663-82. (Pubitemid 38765338)
20. Falagas ME, Makris GC, Karageorgopoulos DE, Batsiou M., Alexiou VG How well do clinical researchers understand risk estimates? Epidemiology 2009 ; 20 (6). 930-1.
21. Katz KA The (relative) risks of using odds ratios. Archives of Dermatology 2006 ; 142 (6). 761-4.